Biozoom announced that the device has entered commercial production. The Biozoom scanner has captured the attention of so many organizations that production has moved from prototype to commercial scale. The Biozoom scanner non-invasively measures and analyzes the biomarkers critical to understanding, managing and improving a user's health and wellness.

The prototype units have been validated in clinical trials and used at respected European institutions. The first commercially produced scanners are expected to be used for large-scale studies by major multinational cosmetics and consumer goods producers, as well as large employers. A portion of the first shipment will be dedicated to market testing in the United States, where health and wellness represent a $150 billion opportunity.